Literature DB >> 16436983

Cochlear implantation of patients with far-advanced otosclerosis.

Julio Rama-López1, Francisco J Cervera-Paz, Manuel Manrique.   

Abstract

OBJECTIVE: This current single-subject, repeated-measures study was to describe our experience with 30 patients who had been diagnosed with "far-advanced otosclerosis" and who were included in our program of cochlear implants. We analyzed the history of the patients and their families before implantation, the surgical findings, and the performance over a follow up of 3 years.
MATERIAL AND METHODS: All patients met one or more of the after criteria: 1) previous surgical intervention as a treatment of their otosclerosis; 2) signs of pericochlear hypodensities in high resolution computed tomography (HRCT) scans; and 3) family precedents of otosclerosis. All underwent standard surgical cochlear implantation.
RESULTS: In 78% of the cases, a stapedectomy had previously been realized. Cochlear otosclerosis could be appreciated in HRCT in 78% of the patients. A family history of otosclerosis was found in 40%, and 33.3% of patients had familial precedents of nonfilial hypoacusis. The mean results in the two-syllable test were 20% preimplantation, 54% 6 months after implantation, and 52%, 62%, 54% at 1, 2, and 3 years after implantation. In the CID sentence test, they were in the order of 32% preimplantation and of 64% at 6 months, 66% after 1 year, of 68% after 2 years, and reaching 72% after 3 years. No complications related to the surgery were detected.
CONCLUSION: Patients diagnosed with far-advanced otosclerosis have a good prognosis with cochlear implantation comparable to that of other patients in whom postlingual implants are performed.

Entities:  

Mesh:

Year:  2006        PMID: 16436983     DOI: 10.1097/01.mao.0000197387.29534.26

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Non-Ototoxic Local Delivery of Bisphosphonate to the Mammalian Cochlea.

Authors:  Woo Seok Kang; Shuting Sun; Kim Nguyen; Boris Kashemirov; Charles E McKenna; S Adam Hacking; Alicia M Quesnel; William F Sewell; Michael J McKenna; David H Jung
Journal:  Otol Neurotol       Date:  2015-07       Impact factor: 2.311

2.  Measurement of Ototoxicity Following Intracochlear Bisphosphonate Delivery.

Authors:  Woo Seok Kang; Kim Nguyen; Charles E McKenna; William F Sewell; Michael J McKenna; David H Jung
Journal:  Otol Neurotol       Date:  2016-07       Impact factor: 2.311

3.  Cochlear implantation among patients with otosclerosis: a systematic review of clinical characteristics and outcomes.

Authors:  Majed Assiri; Tawfiq Khurayzi; Afrah Alshalan; Abdulrahman Alsanosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-17       Impact factor: 2.503

4.  Vestibulo-Cochlear Function After Cochlear Implantation in Patients With Meniere's Disease.

Authors:  Raquel Manrique-Huarte; Diego Calavia; Laura Alvarez-Gomez; Alicia Huarte; Nicolás Perez-Fernández; Manuel Manrique
Journal:  J Int Adv Otol       Date:  2018-04       Impact factor: 1.017

5.  Evaluation of Functional Outcomes after Stapes Surgery in Patients with Clinical Otosclerosis in a Teaching Institution.

Authors:  José Celso Rodriques de Souza; Ricardo Ferreira Bento; Larissa Vilela Pereira; Liliane Ikari; Stephanie Rugeri Souza; Ana Adelina Giantomasi Della Torre; Anna Carolina de Oliveira Fonseca
Journal:  Int Arch Otorhinolaryngol       Date:  2015-11-04

6.  Treatment of moderate-to-severe otosclerosis with simultaneous piston surgery and incus vibroplasty.

Authors:  Chan-Jung Chang; Yu-Hsuan Wen; Chuan-Hung Sun; Millo Achille Beltrame; Hung-Pin Wu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.